Pro- and anti-inflammatory cytokines and osteoclastogenesis-related factors in peri-implant diseases: systematic review and meta-analysis

Abstract

Background Pro- and anti-inflammatory cytokines are acknowledged, during inflammatory bone destruction, as key regulators of osteoclast and osteoblast differentiation and activity. However, evidence regarding the exact role of pro- and anti-inflammatory cytokines and osteoclastogenesis-related factors in peri-implant diseases is unclear. We aimed to execute a systematic review and meta-analysis about the pro- and anti-inflammatory cytokines and osteoclastogenesis-related factors levels in peri-implant diseases. Methods The focused question was elaborated to summarize the levels of pro-and anti-inflammatory cytokines and osteoclastogenesis-related factors in tissue samples (mRNA) and biofluids (protein levels) of patients with/without peri-implant diseases. Electronic searches of the PubMed, Cochrane Controlled Trials Registry, Web of Science, EMBASE, Scopus and Google scholar databases were conducted for publications up to March 2023. Meta-analysis evaluating the mediator´s levels (protein levels by ELISA) in peri-implant crevicular fluid (PICF) were made. The effect size was estimated and reported as the mean difference. The 95% confidence interval was estimated for each mediator, and the pooled effect was determined significant if two-sided p-values < 0.05 were obtained. Results Twenty-two publications were included in the systematic review (qualitative analysis), with nine of these subjected to meta-analyses (quantitative analysis). In the qualitative analysis, higher pro-inflammatory cytokines [Interleukin (IL)-1β, IL-6] and pro-osteoclastogenic mediator [Receptor Activator of Nuclear Factor-Kappa B ligand (RANKL)] levels were observed in PICF of individuals with peri-implant diseases in comparison to healthy individuals. Higher RANKL/osteoprotegerin (OPG) ratios were observed in PICF from individuals with peri-implant diseases in comparison to healthy individuals. Meta-analysis showed higher RANKL levels in diseased groups compared to controls. Conclusions The results showed that the levels of IL-1β, IL-6, IL-10, and RANKL/OPG are not balanced in peri-implant disease, suggesting that these mediators are involved in the host osteo-immunoinflammatory response related to peri-implantitis.

Quantification and Influence of IL-1β on Pain and Inflammatory Response after Placement of a Cement–Screw-Retained Restoration

“…Studies have indicated that painful and inflammatory processes are associated with increased levels of IL-1β. Higher levels of proinflammatory cytokines (interleukin (IL)-1β and IL-6) were observed in individuals with peri-implantitis compared to healthy implants [ 42 , 43 , 44 ]. In this study, similarly, the greater the pain and inflammatory response, the higher the IL-1β levels.…”

Indication-Specific Effect of a Phytotherapeutic Remedy on Human Fetal Osteoblastic Cells: An in vitro Analysis

“…Without a corresponding immune response, healing is not stimulated. The pro-inflammatory cytokines lead downstream of various signaling cascades to an increase in growth factors et altera and pro-inflammatory signals likely interplay with regulators of osteogenesis in bone cells [31,32].…”

Bone Formation and Maintenance in Oral Surgery: The Decisive Role of the Immune System—A Narrative Review of Mechanisms and Solutions

“…The role of the macrophage-osteoclast axis in bone damage is now well documented: bone loss is caused by inflammation and immune diseases [38]. There is strong evidence that the interleukins IL-1β, IL-6 and IL-10 and RANKL with OPG, which inhibits bone resorption and modulates inflammatory responses, are involved in the pathophysiology of peri-implant diseases [39]. T cells have been shown to have capacities to activate osteoclasts and are thus thought to be responsible for bone loss.…”